Our expertise

At the heart of the
radioactive medicine chain

A PET (Positron Emission Tomography) production centre is a unique environment: it produces short-lived radioactive drugs used within hours of synthesis for oncological, neurological and cardiological diagnosis.

A demanding environment

The production of FDG, FCholine or FDOPA requires a cyclotron, radiation shielding, automated chemistry modules and real-time quality control systems. Each batch must be certified before release — within timeframes constrained by radioactive decay.

Why call on ReflectPET

Whether it's a new centre under creation, a compliance audit, an extension project or resolving a recurring technical problem, ReflectPET brings independent, operational and results-oriented external expertise.

PET value chain
Cyclotron
Chemical synthesis
Quality control
Batch release
Distribution
Patient injection
Key figures

A fast-growing market

+300
active PET centres in France and French-speaking countries
511 keV
energy of annihilation photons detected in coincidence
110 min
half-life of fluorine-18, the main isotope used in PET production